Stay updated on Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page
- Check4 days agoChange DetectedMinor revision update: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no visible impact on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLocations were updated with many new sites across the US, Australia, Canada, and Europe, and numerous sites were removed. The entry also shows a page revision tag, Revision: v3.3.3.SummaryDifference3%

- Check55 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed. Updated the revision tag to v3.3.2.SummaryDifference0.3%

- Check62 days agoChange DetectedThe generic government funding operating-status notice was removed, with no changes to the study details or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange DetectedNo additions or deletions affecting the study details were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check105 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.